Home Search Contents Contact Partners

                 BioSignetics Corporation
                                                                    Digital Stethoscope Company                             




BSIGNAL Brings Powerful New Signal Processing Capabilities for Heart Auscultation

BIOSIGNETICS Announces First Release of BSignal Heart Energy Processing Software

August 3rd, 2004, Exeter, NH, USA 

BIOSIGNETICS Announces First Release of BSignal Heart Energy Processing Software

“Heart disease is the leading cause of death in the United States. It affects men and women of every age and race. More than 64 million Americans suffer from one or more forms of cardiovascular disease, including high blood pressure, coronary heart disease, congestive heart failure, stroke, and congenital heart defects”, indicated President G.W. Bush in his proclamation devoted to the American Hear Month 2004 [1]. President encouraged all Americans “to join the fight against heart disease and to learn more about how to prevent it”.

Joining this fight, Biosignetics Corporation (www.bsignetics.com) , the world’s leading provider of biosignature and dynamic energy signature analysis software and consulting services, announces the availability of BSignal 1.0 (beta). This first commercial release of the software brings many new possibilities in the sound based characterization of auscultatory documented human heart conditions (stenosis, regurgitation, splits, clicks, gallops, snaps, rumble, valve prolapse, murmurs, septal defect, patent ductus arteriosus, atrial septal defect).

BSignal incorporates a newly developed revolutionary technology to establish unique dynamic Heart Energy Signature (HES) and to track its evolution over time. This software allows converting complex multi-component non-gaussian heart sounds into simple and self-referencing X-ray-like images.

HES has a great potential to become de-facto standard to record, store, compare and track sound based heart diagnosis data. It can be especially effective in heart disease related research and in educating medical students and doctors to perform auscultation more effectively.

Present release incorporates user-friendly GUI with the powerful signal simulation tools that include signal processing filters, data reduction techniques with wavelets, spectrum, joint time frequency transformation, image manipulation techniques and the database of various heart sounds.


BSignal is available for PC windows NT, Win2000 and XP platforms. It is available in several versions. Light version BSignal - Phonocardiograph is a Class I medical device (FDA Sec 870.2390). It is presently available in educational version; clinical release is scheduled for Fall 2004. Full-featured BSignal – Heart Energy Signature version is only presently available for educational purposes and for non-clinical research applications.

It can also be effectively utilized in other non-clinical applications such as “brain fingerprinting” and various analyses related to EEC and brain wave interpretations. Special version of BSignal –MHM is available for machine health monitoring and diagnosis, helicopter gearboxes, and joint-time frequency domain based signal processing. It contains set of specialized criteria for automatic mechanical failure detection.

                                       Heart Energy Signature

                               S2                                       S1

                        Phonocardiograph Signal Representation
Copyright 2004, Biosignetics Corp.

                 Identification of Early Systolic Murmur following S1 Sound
Copyright 2004, Biosignetics Corp.



                     HES Normal Heart

       HES of Atrial Septal Defect (ASD)

                                                                                              Copyright 2004, Biosignetics Corp


Biosignetics has developed and commercialized patent pending Heart Energy Signature format and method. Company continues its research and regulatory efforts to prepare 510(K) FDA application for clinical diagnosis version. Biosignetics is aggressively engaged in early detection research focusing on reliable detection of weak multi-component signals and patterns in otherwise noisy environment and is actively looking for clinical research partners in the medical community.

American Heart Month 2004, By the President of the United States of America A Proclamation   

For More Information Contact:
Vladimir Kudriavtsev
VP Marketing and Technology
BioSignetics Corporation
29 Downing Ct, Exeter, NH 03833
Tel: 416-497-2356, 603-303-0708
FAX: 603 772-8706
Internet: info@bsignetics.com

All Materials and Images are subject to the Copyright.
Copyright: 2004-2009 BioSignetics Corporation
Last modified: 02/02/09